Tigenix The Latest To Find Stem Cell Appetite In Japan – Seeking Alpha
|
Tigenix The Latest To Find Stem Cell Appetite In Japan
Seeking Alpha Tigenix (OTC:TGXSF) is lucky that Japanese companies are still willing to bet against the odds on stem cell therapies. Otherwise it would have struggled to license out Cx601 – Takeda (OTCPK:TKPYY) emerged as its ex-US partner today – and gloss over the … TiGenix licenses ex-US rights for Cx601 stem cell treatment to Takeda Takeda snatches up Belgian Cell therapy for Crohn's Disease |
